Processing

Please wait...

Settings

Settings

Goto Application

1. WO1990003973 - PYRIMIDINYL-SUBSTITUTED HYDROXYACIDS, LACTONES AND ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publication Number WO/1990/003973
Publication Date 19.04.1990
International Application No. PCT/EP1989/000225
International Filing Date 06.03.1989
IPC
C07D 239/26 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
26with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D 239/42 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
32One oxygen, sulfur or nitrogen atom
42One nitrogen atom
C07D 401/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
C07D 405/06 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
CPC
A61P 3/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
06Antihyperlipidemics
A61P 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C07D 239/26
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
26with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D 239/42
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
32One oxygen, sulfur or nitrogen atom
42One nitrogen atom
C07D 401/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
C07D 405/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
Applicants
  • SANDOZ AG [CH]/[CH]
Inventors
  • KATHAWALA, Faizulla, Gulamhusein
Priority Data
254,51406.10.1988US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PYRIMIDINYL-SUBSTITUTED HYDROXYACIDS, LACTONES AND ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
(FR) HYDROXY ACIDES, LACTONES ET ESTERS A SUBSTITUTION PYRIMIDINYLE ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES
Abstract
(EN)
Compounds of formula (I), wherein R1, R2, Q, X and Y have various significances, in free acid form, or in the form of an ester or $g(d)-lactone thereof, or in salt form as appropriate, are described. They are indicated for use as hypolipoproteinemic and anti-atherosclerotic agents. They may be obtained by reduction, hydrolysis, deprotection or oxidation of appropriate starting compounds, and variously interconverted by e.g. hydrolysis, salt formation, esterification and/or lactonisation.
(FR)
Les composés décrits, qui sont représentés par la formule (I), où R1, R2, Q, X et Y ont diverses significations, peuvent se présenter sous la forme d'un acide libre ou sous la forme d'un ester ou d'une $g(d)-lactone de cet acide ou encore sous la forme d'un sel, selon la convenance. Ces composés sont indiqués pour être utilisés comme agents d'hypolipoprotéinémie ou anti-artériosclérose. Ils peuvent être obtenus par réduction, hydrolyse, déprotection ou oxydation de composés de départ appropriés et ils peuvent être diversement convertis entre eux, par exemple par hydrolyse, formation de sels, estérification et/ou lactonisation.
Other related publications
Latest bibliographic data on file with the International Bureau